VQI生存预测模型在无血运重建选择危重肢体缺血患者中的外部验证
本研究将基于血运重建VQI队列开发的生存预测模型,应用于西欧无血运重建选择的危重肢体缺血(CLTI)队列(N=150),比较2年估计死亡率与观察死亡率。验证队列2年生存率为79%,VQI队列为83%;
要点
- VQI生存模型在无血运重建选择的CLTI人群中区分度良好,C统计量0.86。
- 验证队列2年生存率79%,与VQI队列83%接近。
- 17个基线变量中13个存在显著差异,提示人群异质性。
核心结论
- VQI生存预测模型首次外部验证显示性能良好,可适用于包括无血运重建选择CLTI在内的不同CLTI人群。
研究设计与样本
- 将基于血运重建VQI队列开发的生存预测模型应用于西欧无血运重建选择CLTI验证队列(N=150),比较基线后2年估计死亡率与观察死亡率。
- 采用受试者工作特征曲线下面积评价区分度,采用Hosmer-Lemeshow拟合优度检验评价校准度。
主要发现
- 验证队列2年生存率为79%,VQI队列为83%。
- 17个基线特征变量中有13个存在显著差异。
- C统计量为0.86(95%CI 0.78-0.95),提示区分度良好。
关键数值与推荐
- 验证队列2年生存率79%,VQI队列83%。
- C统计量0.86(95%CI 0.78-0.95)。
- 17个基线变量中13个显著不同。
临床怎么用
- 该模型可用于无血运重建选择CLTI患者的个体化生存预测,辅助治疗策略制定。
- 模型在不同CLTI人群中表现良好,支持其跨人群推广应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Chronic limb-threatening ischemia (CLTI) is associated with high morbidity and mortality rates. More than 50% of all CLTI patients die within 5 years after presentation. Patient-specific survival prediction is critical for informing treatment strategies, even for those without a clear option for revascularization. We validated a survival prediction model, developed in a revascularized Vascular Quality Initiative (VQI) cohort, in a Western European no-option CLTI cohort. METHODS: The VQI survival prediction model was applied to the validation cohort (N = 150) to compare estimated mortality and observed mortality at 2 years after baseline. Performance of the VQI model was tested by evaluating discrimination using the receiver operating characteristic area under the curve and calibration using the Hosmer-Lemeshow goodness-of-fit test. RESULTS: The 2-year survival rate was 79% in the validation cohort compared with 83% in the VQI cohort. Baseline characteristics were significantly different for 13 of 17 variables. The C statistic was 0.86 (95% confidence interval, 0.78-0.95), which indicates good discrimination. The Hosmer-Lemeshow goodness-of-fit test had a P value of .30, which indicates good fit. CONCLUSIONS: This is the first external validation of the VQI survival prediction model. The good model performance suggests that this model can be used in different CLTI populations, including no-option CLTI, and underlines its contributory role in this challenging population.
引用
- Verwer MC, Wijnand JGJ, Teraa M, et al. External validation of the Vascular Quality Initiative prediction model for survival in no-option chronic limb-threatening ischemia patients. J Vasc Surg. 2020. PMID: 32249040. doi:10.1016/j.jvs.2020.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。